Advertisement
Person › Details
Naheed Kurji (Cyclica Inc.)
Kurji, Naheed (Cyclica 201811 CEO)
Organisation | Cyclica Inc. | |
Product | drug discovery software | |
Product 2 | artificial intelligence (AI) / machine learning (ML) | |
Cyclica Inc.. (11/26/18). "Press Release: Cyclica Drives Drug Discovery through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer". Toronto.
Cyclica (www.cyclicarx.com), a Bayer G4A company is pleased to announce a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small molecules, while further evolving Cyclica’s integrated network of enabling technologies.
Through a multi-phase collaboration, Cyclica will provide its cloud-based proteome screening Ligand Express® platform to investigate the off-target profiles of small molecules, apply its novel and proprietary advanced AI technology to create state-of-the-art predictive models for pharmacokinetic properties, and leverage its first-in-class Differential Drug Design (DDD) technology for multi-targeted drug design.
Naheed Kurji, President and CEO of Cyclica said, “We are thrilled to have the opportunity to work closely with the world-leading scientists at Bayer to advance drug discovery through a holistic set of AI-augmented technologies, and to learn from their experience and expertise to enhance our forthcoming innovation. Securing this collaboration with Bayer, which was catalyzed by our participation in the G4A program, is a testament to Cyclica’s value proposition.”
About Cyclica:
Cyclica is a Toronto-based biotechnology company that is driving drug discovery by empowering scientists in pharma with an integrated cloud-based and AI-augmented platform that enhances how they design, screen and personalize medicines. To learn more, visit www.cyclicarx.com.
Contacts
Media Inquires:
Naheed Kurji
President and CEO
Cyclica Inc
naheed.kurji@cyclicarx.com
Record changed: 2021-03-22 |
Advertisement
More documents for Naheed Kurji
- [1] Cyclica Inc.. (10/8/19). "Press Release: To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships". Toronto....
- [2] Merck KGaA. (12/6/18). "Press Release: Merck in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities". Darmstadt....
- [3] Cyclica Inc.. (11/26/18). "Press Release: Cyclica Drives Drug Discovery through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer". Toronto....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top